Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-03

Clinical Trial Update: Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating the efficacy and safety of paclitaxel polymeric micelles for injection in patients with taxane-resistant pancreatic cancer, ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paclitaxel (polymeric micelle formulation) for injection (paclitaxel)

Snippet

Sponsor: Liu Huang | Conditions: Pancreatic Adenocarcinoma, Cholangiocarcinoma | Phase 2 | Status: RECRUITING